lutetium has been researched along with Peritoneal Carcinomatosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| de Feijter, JM; Seijkens, TTP; van Golen, LW; Vogel, W | 1 |
| Aarts, F; Bleichrodt, RP; Boerman, OC; de Man, B; Hendriks, T; Lomme, R | 1 |
| Beck, R; Bruchertseifer, F; Quintanilla-Martinez, L; Seidl, C; Senekowitsch-Schmidtke, R; Zöckler, C | 1 |
| Buchsbaum, DJ; Roberson, PL; Rogers, BE; Yokoyama, S | 1 |
| Bleichrodt, RP; Boerman, OC; Goldenberg, DM; Koppe, MJ; Oyen, WJ; Soede, AC; Verhofstad, AA | 1 |
| Aarts, F; Bleichrodt, RP; Boerman, OC; Hendriks, T; Koppe, MJ; Oyen, WJ | 1 |
6 other study(ies) available for lutetium and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Peritoneal Metastases From Prostate Carcinoma Treated With 177 Lu-PSMA-I&T.
Topics: Aged; Carcinoma; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2023 |
The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat.
Topics: Abdominal Wall; Anastomosis, Surgical; Animals; Antibiotics, Antineoplastic; Chemotherapy, Cancer, Regional Perfusion; Colonic Neoplasms; Combined Modality Therapy; Disease Models, Animal; Gelatinases; Hydroxyproline; Hyperthermia, Induced; Injections, Intraperitoneal; Intestines; Lutetium; Male; Mitomycin; Peritoneal Neoplasms; Radioimmunotherapy; Rats; Rats, Inbred Strains; Survival Rate; Treatment Outcome; Wound Healing | 2008 |
177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi.
Topics: Animals; Antibodies, Monoclonal; Bismuth; Blood Cell Count; Cell Line, Tumor; Disease Models, Animal; Drug Stability; Female; Humans; Immunoconjugates; Lutetium; Mice; Peritoneal Neoplasms; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Stomach Neoplasms; Time Factors | 2011 |
Three-dimensional dose model for the comparison of 177Lu-HuCC49DeltaCH2 and 177Lu-HuCC49 radioimunotherapy in mice bearing intraperitoneal xenografts.
Topics: Aniline Compounds; Animals; Antibodies, Monoclonal; Colonic Neoplasms; Dose-Response Relationship, Radiation; Heterocyclic Compounds; Humans; Lutetium; Mice; Mice, Nude; Models, Biological; Neoplasms, Experimental; Peritoneal Neoplasms; Radioimmunotherapy; Radiotherapy Dosage; Tissue Distribution; Transplantation, Heterologous | 2003 |
Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Topics: Animals; Antibodies, Monoclonal; Colorectal Neoplasms; Injections, Intraperitoneal; Injections, Intravenous; Iodine Radioisotopes; Lutetium; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Organ Specificity; Peritoneal Neoplasms; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Reproducibility of Results; Rhenium; Sensitivity and Specificity; Tissue Distribution; Yttrium Radioisotopes | 2004 |
A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Body Weight; Colonic Neoplasms; Combined Modality Therapy; Disease Models, Animal; Hyperthermia, Induced; Infusions, Parenteral; Lutetium; Mitomycin; Neoplasms, Experimental; Peritoneal Neoplasms; Radioimmunotherapy; Rats; Rats, Inbred Strains; Survival Rate; Treatment Outcome | 2007 |